EUDA Health (EUDA) Competitors $2.73 -0.01 (-0.51%) As of 02:43 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock EUDA vs. XGN, DCGO, CORBF, SERA, QIPT, BNR, PIII, ATPC, BDSX, and BMGLShould you be buying EUDA Health stock or one of its competitors? The main competitors of EUDA Health include Exagen (XGN), DocGo (DCGO), Global Cord Blood (CORBF), Sera Prognostics (SERA), Quipt Home Medical (QIPT), Burning Rock Biotech (BNR), P3 Health Partners (PIII), Agape ATP (ATPC), Biodesix (BDSX), and Basel Medical Group (BMGL). These companies are all part of the "healthcare" industry. EUDA Health vs. Its Competitors Exagen DocGo Global Cord Blood Sera Prognostics Quipt Home Medical Burning Rock Biotech P3 Health Partners Agape ATP Biodesix Basel Medical Group EUDA Health (NASDAQ:EUDA) and Exagen (NASDAQ:XGN) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, profitability, institutional ownership, risk, dividends and earnings. Does the media prefer EUDA or XGN? In the previous week, Exagen had 3 more articles in the media than EUDA Health. MarketBeat recorded 5 mentions for Exagen and 2 mentions for EUDA Health. EUDA Health's average media sentiment score of 1.54 beat Exagen's score of 0.64 indicating that EUDA Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment EUDA Health 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Exagen 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk and volatility, EUDA or XGN? EUDA Health has a beta of -0.14, indicating that its stock price is 114% less volatile than the S&P 500. Comparatively, Exagen has a beta of 1.54, indicating that its stock price is 54% more volatile than the S&P 500. Is EUDA or XGN more profitable? EUDA Health has a net margin of 0.00% compared to Exagen's net margin of -28.85%. EUDA Health's return on equity of 0.00% beat Exagen's return on equity.Company Net Margins Return on Equity Return on Assets EUDA HealthN/A N/A N/A Exagen -28.85%-130.38%-34.69% Which has stronger earnings and valuation, EUDA or XGN? Exagen has higher revenue and earnings than EUDA Health. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEUDA Health$4.01M25.26-$15.36MN/AN/AExagen$55.64M4.27-$15.11M-$0.89-12.14 Do insiders and institutionals hold more shares of EUDA or XGN? 4.4% of EUDA Health shares are owned by institutional investors. Comparatively, 75.3% of Exagen shares are owned by institutional investors. 12.6% of Exagen shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Do analysts prefer EUDA or XGN? Exagen has a consensus target price of $12.00, suggesting a potential upside of 11.06%. Given Exagen's stronger consensus rating and higher probable upside, analysts clearly believe Exagen is more favorable than EUDA Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score EUDA Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.50Exagen 1 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.78 SummaryExagen beats EUDA Health on 9 of the 15 factors compared between the two stocks. Get EUDA Health News Delivered to You Automatically Sign up to receive the latest news and ratings for EUDA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding EUDA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EUDA vs. The Competition Export to ExcelMetricEUDA HealthMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$101.45M$2.22B$6.03B$10.35BDividend YieldN/AN/A5.66%4.69%P/E RatioN/A37.6085.4326.75Price / Sales25.2613.58584.59179.25Price / CashN/A62.4838.3262.20Price / Book-38.9413.1112.766.61Net Income-$15.36M-$63.46M$3.30B$275.78M7 Day Performance22.24%-1.61%1.60%-0.43%1 Month Performance96.12%4.96%8.18%6.31%1 Year Performance-27.50%43.40%80.39%33.17% EUDA Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EUDAEUDA Health1.2369 of 5 stars$2.73-0.5%N/A-27.5%$101.45M$4.01M0.002Gap UpXGNExagen4.1084 of 5 stars$10.99+2.0%$12.00+9.2%+307.4%$236.98M$55.64M-12.35220Analyst ForecastHigh Trading VolumeDCGODocGo1.912 of 5 stars$1.36-1.4%$3.24+138.1%-62.5%$134.98M$616.55M-7.164,407News CoverageAnalyst DowngradeCORBFGlobal Cord BloodN/A$1.01+1.0%N/AN/A$122.77M$196.12M0.001,200Gap UpSERASera Prognostics1.243 of 5 stars$3.06+0.3%N/A-50.2%$114.90M$80K-3.60120Positive NewsAnalyst ForecastQIPTQuipt Home Medical2.8788 of 5 stars$2.61-0.4%$3.15+20.7%-6.7%$113.82M$245.91M-10.871,200Positive NewsAnalyst ForecastBNRBurning Rock Biotech0.8235 of 5 stars$8.65-7.9%N/A+152.4%$101.05M$70.67M-4.551,390News CoverageAnalyst ForecastPIIIP3 Health Partners2.8127 of 5 stars$8.94-7.0%$16.25+81.8%-43.7%$69.09M$1.50B-0.19500News CoverageAnalyst ForecastATPCAgape ATP0.6524 of 5 stars$1.27+1.2%N/A-32.0%$62.51M$1.32M-3.0940Positive NewsAnalyst ForecastHigh Trading VolumeBDSXBiodesix3.3266 of 5 stars$7.55-2.5%$32.50+330.5%-76.1%$56.75M$71.32M-1.30220Analyst ForecastBMGLBasel Medical GroupN/A$1.82+1.7%N/AN/A$33.03MN/A0.0036Positive NewsAnalyst Forecast Related Companies and Tools Related Companies Exagen Competitors DocGo Competitors Global Cord Blood Competitors Sera Prognostics Competitors Quipt Home Medical Competitors Burning Rock Biotech Competitors P3 Health Partners Competitors Agape ATP Competitors Biodesix Competitors Basel Medical Group Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:EUDA) was last updated on 10/10/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredThe 7 Warning Signals Flashing Red Right NowA free report revealing the 7 key indicators that have predicted every major economic collapse since 1929. ...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding EUDA Health Holdings Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share EUDA Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
